The gradual accumulation and prion-like propagation of α -synuclein and other amyloidogenic proteins is associated with devastating neurodegenerative diseases. The metazoan disaggregation machinery, a specific combination of HSP70 and its co-chaperones, is able to disassemble α -synuclein fibrils in vitro, but the physiological consequence in vivo is unknown. To explore this, we used Caenorhabditis elegans models that exhibit pathological features of 6
RESULTS
Tissue-specific KD of HSP-110 prevents disassembly of HS-induced firefly luciferase aggregatesOur previous work revealed that a specific human HSP70-DNAJ-HSP110 network exhibits in vitro disaggregation activity towards amyloid α -Syn fibrils and detergent insoluble α -Syn extracted from C. elegans (Gao et al., 2015). However, its effect on aggregation and toxicity of α -Syn in vivo has yet to be addressed. Two scenarios are conceivable. The disaggregation activity could either lead to a resolubilization and refolding of aggregated α -Syn, which would result in reduced toxicity. Alternatively, it could contribute to the multiplication ofα -Syn aggregates by continuously generating new seeds by fragmentation, analogous to the function of HSP104 and the HSP70-DNAJ system in yeast prion propagation, which would likely increase toxicity.In an effort to assess the role of the metazoan disaggregation machinery in amyloid aggregate propagation in vivo, we employed C. elegans as model organism. Members of the nematode disaggregation system are highly conserved, but less redundant than in the human system (Kirstein et al., 2017).